TIRBANIBULIN (Klisyri®)
Clinical Indication
Grade 1 Actinic Keratoses for the face and scalp
Comments
Single treatment course only – not to be repeated.
Date of classification
November 2023
Green
Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.